Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The new online Learning Center with new content can still be found under the “Training” folder on ...
We are very excited to launch our new website! Please take a few moments to click around and explore...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...